Clinical Trial Update: Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation [NA]

View source ↗

Summary

Clinical trial update indicating termination of an Alefacept plus allogeneic hematopoietic stem cell transplantation study, with results posted in 2015 for mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Neutropenia
• Glanzmann Thrombasthenia
• Granulomatous Disease
• Leukocyte Adhesion Deficiency
• Schwachman-diamond Syndrome
• Sickle Cell Disease
• Thalassemia
• Wiskott-aldrich Syndrome

Drugs mentioned

• Amevive (alefacept)

Snippet

Sponsor: Emory University | Conditions: Thalassemia, Sickle Cell Disease | NA | Status: TERMINATED | Results posted: 2015-03-09